FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

116551004: Phenyltoloxamine citrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
203177017 Phenyltoloxamine citrate en Synonym Active Entire term case insensitive SNOMED CT core module
679589015 Phenyltoloxamine citrate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Phenyltoloxamine citrate Is a Product containing ethanolamine derivative and histamine receptor antagonist false Inferred relationship Existential restriction modifier
Phenyltoloxamine citrate Is a Sedating antihistamine false Inferred relationship Existential restriction modifier
Phenyltoloxamine citrate Is a Phenyltoloxamine false Inferred relationship Existential restriction modifier
Phenyltoloxamine citrate Has disposition Histamine receptor antagonist true Inferred relationship Existential restriction modifier
Phenyltoloxamine citrate Is modification of Phenyltoloxamine true Inferred relationship Existential restriction modifier
Phenyltoloxamine citrate Is a Ethanolamine derivative with histamine receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg m/r capsule Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 2.5mg/5mL 5mg/5mL 7.5mg/5mL liquid Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Acetaminophen + phenyltoloxamine citrate 500mg/30mg caplets Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 60 milligram/1 each conventional release oral tablet Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Product containing paracetamol and phenyltoloxamine citrate Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Product containing paracetamol and phenyltoloxamine citrate and salicylamide Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Has basis of strength substance True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 60 milligram/1 each conventional release oral tablet Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 60 milligram/1 each conventional release oral tablet Has basis of strength substance False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Has basis of strength substance False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has basis of strength substance False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 3
Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Has basis of strength substance True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has basis of strength substance False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has basis of strength substance False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet Has basis of strength substance False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Has precise active ingredient True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Has precise active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has precise active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 60 milligram/1 each conventional release oral tablet Has precise active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has precise active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet Has precise active ingredient False Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has basis of strength substance True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule Has precise active ingredient True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has basis of strength substance True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral tablet Has precise active ingredient True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 60 milligram/1 each conventional release oral tablet Has basis of strength substance True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 60 milligram/1 each conventional release oral tablet Has precise active ingredient True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet Has precise active ingredient True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet Has precise active ingredient True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1
Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet Has basis of strength substance True Phenyltoloxamine citrate Inferred relationship Existential restriction modifier 1

This concept is not in any reference sets

Back to Start